author-photo

Santiago Escrivá

Hebron University

9

Papers

23

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Abstract B63: Clearance of ctDNA in triple-negative and Her2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response

2020
Show All
- Source
- Cite
- Save
Citations (0)
Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) + Ctx versus trastuzumab (T) + Ctx in patients (pts) with pretreated HER2+ metastatic (met) breast cancer (MBC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Concordance of genomic alterations (GA) in synchronous tumor biopsies (tBx) and circulating tumor (ct) DNA from metastatic breast cancer (MBC) patients (pts).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Changes in Ki 67 expression after neoadjuvant therapy in HER2 positive breast cancer patients treated with trastuzumab and pertuzumab are independent predictors of response and prognosis

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
218PPrognostic estimates of Ki-67 percentage drop after neoadjuvant chemotherapy (NAC) in luminal B (lumB) and triple negative breast cancer (TNBC)

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)